Vaccinex, Inc. (VCNX)

Vaccinex Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	11	8	28	32	46	72
Market Cap Growth	-66.81%	-69.83%	-14.05%	-30.87%	-35.72%	72.34%
Enterprise Value	8	7	22	24	45	69
PE Ratio	-	-0.41	-1.39	-1.43	-1.61	-2.26
PS Ratio	85.35	14.57	100.12	35.59	74.14	137.83
PB Ratio	3.99	-3.59	5.30	4.32	-1.74	-2.75
P/FCF Ratio	-0.39	-0.48	-1.44	-1.26	-1.60	-2.34
P/OCF Ratio	-0.39	-0.48	-1.44	-1.27	-1.62	-2.35
EV/Sales Ratio	62.11	12.31	78.64	26.48	71.92	132.52
EV/EBITDA Ratio	-0.20	-0.35	-1.10	-1.11	-1.60	-2.19
EV/EBIT Ratio	-0.19	-0.35	-1.09	-1.10	-1.58	-2.18
EV/FCF Ratio	-0.22	-0.41	-1.13	-0.94	-1.55	-2.25
Debt / Equity Ratio	0.07	-0.11	0.09	0.05	-0.35	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-0.02	-0.33	-
Debt / FCF Ratio	-0.01	-0.01	-0.03	-0.02	-0.32	-
Quick Ratio	1.24	0.42	2.59	3.81	0.82	0.53
Current Ratio	1.52	0.57	2.95	4.17	0.86	0.58
Asset Turnover	0.03	0.16	0.02	0.05	0.07	0.06
Interest Coverage	-	-20250.00	-9906.50	-26.66	-58.00	-
Return on Equity (ROE)	1943.90%	1927.30%	-205.10%	-241.60%	113.10%	141.20%
Return on Assets (ROA)	-461.20%	-571.70%	-167.60%	-112.60%	-300.50%	-355.70%
Return on Capital (ROIC)	-808.91%	1108.77%	-350.58%	-288.26%	163.13%	122.02%
Earnings Yield	-181.29%	-243.81%	-71.97%	-69.87%	-62.26%	-44.20%
FCF Yield	-159.16%	-208.29%	-69.64%	-79.07%	-62.45%	-42.72%
Buyback Yield / Dilution	-458.78%	-129.44%	-47.10%	-53.56%	-45.85%	-146.59%
Total Shareholder Return	-458.78%	-129.44%	-47.10%	-53.56%	-45.85%	-146.59%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).